Takeaways from the MedTech Conference 2024

The recent MedTech Conference in Canada showcased the Industry’s remarkable growth and resilience.

AI and GENAI Devices dominated discussions and the need for stringent post-market surveillance. With MedTech sales set to exceed $600 billion by 2025, the event highlighted the future potential for the industry.

Key insights from the event:

1. Significant growth areas: anticipated in the cardiovascular sector and in wearables as health management tools
2. FDA’s home healthcare focus: how to enhance access for minority communities, reflecting a commitment to health equity
3. Regulatory shifts and logistics hubs: how China’s regulatory changes aim to meet increasing demand. Meanwhile, Singapore is rapidly becoming the logistics hub for Asia’s supply chain
4. EO (Ethylene Oxide) sterilisation: expected to remain a cornerstone for at least another decade despite ongoing searches for alternatives
5. Industry innovation: the conference highlighted the MedTech industry’s innovative spirit and transformative future trajectory

The conference set the stage for the transformative potential of the MedTech industry. We look forward to returning to continue our journey in this ever-evolving field at next year's event in San Diego, California.